The cannabinoid-derived pharmaceutical market is expanding as researchers, healthcare providers, and pharmaceutical companies study standardized cannabinoid-based medicines for selected medical uses. The market was valued at USD 8.4 billion in 2024 and is projected to reach USD 25 billion by 2035, growing at a CAGR of 10.4%.
The Cannabinoid-Derived Pharmaceutical...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek